271 related articles for article (PubMed ID: 16386623)
1. Decreased levels of serum immunoglobulins as a risk factor for infection after heart transplantation.
Sarmiento E; Rodríguez-Molina J; Muñoz P; Fernández-Yánez J; Palomo J; Fogueda M; Fernández-Cruz E; Bouza E; Carbone J
Transplant Proc; 2005 Nov; 37(9):4046-9. PubMed ID: 16386623
[TBL] [Abstract][Full Text] [Related]
2. IgG monitoring to identify the risk for development of infection in heart transplant recipients.
Sarmiento E; Rodriguez-Molina JJ; Fernandez-Yañez J; Palomo J; Urrea R; Muñoz P; Bouza E; Fernandez-Cruz E; Carbone J
Transpl Infect Dis; 2006 Mar; 8(1):49-53. PubMed ID: 16623821
[TBL] [Abstract][Full Text] [Related]
3. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
Wieneke H; Otte B; Lang D; Heidenreich S
Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
[TBL] [Abstract][Full Text] [Related]
5. The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections.
Carbone J; Sarmiento E; Palomo J; Fernandez-Yañez J; Muñoz P; Bouza E; Rodríguez-Molina J; Lanio N; Fernandez-Cruz E
Transplant Proc; 2007 Sep; 39(7):2385-8. PubMed ID: 17889198
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an immunological score to assess the risk of severe infection in heart recipients.
Sarmiento E; Navarro J; Fernandez-Yañez J; Palomo J; Muñoz P; Carbone J
Transpl Infect Dis; 2014 Oct; 16(5):802-12. PubMed ID: 25179534
[TBL] [Abstract][Full Text] [Related]
7. Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk for development of infection.
Carbone J; Micheloud D; Salcedo M; Rincon D; Bañares R; Clemente G; Jensen J; Sarmiento E; Rodriguez-Molina J; Fernandez-Cruz E
Transpl Infect Dis; 2008 Dec; 10(6):396-402. PubMed ID: 18657086
[TBL] [Abstract][Full Text] [Related]
8. Assessing the risk of infection and rejection in Hispanic renal transplant recipients by means of an adenosine triphosphate release assay.
Cadillo-Chávez R; de Echegaray S; Santiago-Delpín EA; Rodríguez-Trinidad AT; Camacho-Carrazo B; Alfaro T; Saavedra-Pozo M; Carrasquillo L; González-Caraballo ZA; Morales-Otero LA
Transplant Proc; 2006 Apr; 38(3):918-20. PubMed ID: 16647510
[TBL] [Abstract][Full Text] [Related]
9. Impact of Chlamydia pneumoniae infection on survival rate after heart transplantation.
Pieniazek P; Stepień E; Sadowski J; Przewłocki T; Sokołowski A; Podolec P; Kapelak B; Przybyłowski P; Kadzielski A; Tracz W
Med Sci Monit; 2003 Feb; 9(2):CR67-72. PubMed ID: 12601289
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of cytomegalovirus disease after heart transplantation: persistence of anti-cytomegalovirus IgM antibodies.
Iberer F; Halwachs-Baumann G; Rödl S; Pleisnitzer A; Wasler A; Auer T; Petutschnigg B; Müller H; Tscheliessnigg K; Wilders-Truschnig M
J Heart Lung Transplant; 1994; 13(3):405-11. PubMed ID: 8061015
[TBL] [Abstract][Full Text] [Related]
11. Hypogammaglobulinemia in liver transplant recipients: incidence, timing, risk factors, and outcomes.
Doron S; Ruthazer R; Werner BG; Rabson A; Snydman DR
Transplantation; 2006 Mar; 81(5):697-703. PubMed ID: 16534471
[TBL] [Abstract][Full Text] [Related]
12. Limited cytomegalovirus-specific immunoglobulin M and immunoglobulin G profiles in heart transplant recipients.
Allen MD; Denny CF; Kruse AP; Revkin JH; Fishbein DP; Ashley RL
J Heart Lung Transplant; 1991; 10(5 Pt 1):664-73. PubMed ID: 1659902
[TBL] [Abstract][Full Text] [Related]
13. Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection.
Potena L; Holweg CT; Chin C; Luikart H; Weisshaar D; Narasimhan B; Fearon WF; Lewis DB; Cooke JP; Mocarski ES; Valantine HA
Transplantation; 2006 Aug; 82(3):398-405. PubMed ID: 16906040
[TBL] [Abstract][Full Text] [Related]
14. Hypogammaglobulinemia: Incidence, risk factors, and outcomes following pediatric lung transplantation.
Robertson J; Elidemir O; Saz EU; Gulen F; Schecter M; McKenzie E; Heinle J; Smith E; Mallory G
Pediatr Transplant; 2009 Sep; 13(6):754-9. PubMed ID: 19067916
[TBL] [Abstract][Full Text] [Related]
15. Time-course changes of serum immunoglobulins (IgA, IgG, IgM) after liver transplantation for alcoholic cirrhosis.
González-Quintela A; López-Ben S; Pérez LF; Graña B; Varela M; Tomé S; Varo E
Transpl Immunol; 2003; 11(1):73-7. PubMed ID: 12727478
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile-associated diarrhea in heart transplant recipients: is hypogammaglobulinemia the answer?
Muñoz P; Giannella M; Alcalá L; Sarmiento E; Fernandez Yañez J; Palomo J; Catalán P; Carbone J; Bouza E
J Heart Lung Transplant; 2007 Sep; 26(9):907-14. PubMed ID: 17845929
[TBL] [Abstract][Full Text] [Related]
17. CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
Bonaros N; Mayer B; Schachner T; Laufer G; Kocher A
Clin Transplant; 2008; 22(1):89-97. PubMed ID: 18217909
[TBL] [Abstract][Full Text] [Related]
18. Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections.
Carbone J; Sarmiento E; Del Pozo N; Rodriguez-Molina JJ; Navarro J; Fernandez-Yañez J; Palomo J; Villa A; Muñoz P; Fernandez-Cruz E
Clin Transplant; 2012; 26(3):E277-83. PubMed ID: 22686951
[TBL] [Abstract][Full Text] [Related]
19. Decreased levels of serum complement C3 and natural killer cells add to the predictive value of total immunoglobulin G for severe infection in heart transplant recipients.
Sarmiento E; del Pozo N; Gallego A; Fernández-Yañez J; Palomo J; Villa A; Ruiz M; Muñoz P; Rodríguez C; Rodríguez-Molina J; Navarro J; Kotsch K; Fernandez-Cruz E; Carbone J
Transpl Infect Dis; 2012 Oct; 14(5):526-39. PubMed ID: 23013361
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with cytomegalovirus infection in orthotopic liver transplant patients.
Hoppe L; Marroni CA; Bressane R; Lago L; Schiavo FL; Cigerza GC; Brandão AB; Zanotelli ML; Cantisani GP
Transplant Proc; 2006; 38(6):1922-3. PubMed ID: 16908324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
